Zika Virus Serological Reagents
QFO is the FDA product code for Zika Virus Serological Reagents, a class II device type, regulated under 21 CFR 866.3935. FDA's definition for this code reads: "Zika virus serological reagents are devices that consist of antigens and antisera for the diagnosis of Zika virus infection in human clinical specimens from individuals that have signs and symptoms consistent with Zika virus infection and/or epidemiological risk factors. The device aids in the presumptive clinical...". As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QFO
- Device name
- Zika Virus Serological Reagents
- FDA definition
- Zika virus serological reagents are devices that consist of antigens and antisera for the diagnosis of Zika virus infection in human clinical specimens from individuals that have signs and symptoms consistent with Zika virus infection and/or epidemiological risk factors. The device aids in the presumptive clinical diagnosis of Zika virus infection in conjunction with other clinical and laboratory findings.
- Regulation
- 21 CFR 866.3935
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 4
- Ingested recalls
- 0
Clearances, product code QFO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2019 | 3 |
| 2020 | 1 |
Applicants with the most clearances
Product code QFO| Applicant | Clearances |
|---|---|
| Chembio Diagnostic Systems, Inc. | 1 |
| Diasorin Inc. | 1 |
| Inbios International, Inc. | 1 |
| Siemens Healthcare Diagnostics Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
